MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
+0.19%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$200M
AUM Growth
+$200M
(-11%)
Cap. Flow
-$32.1M
Cap. Flow
% of AUM
-16.06%
Top 10 Holdings %
Top 10 Hldgs %
59.89%
Holding
71
New
13
Increased
14
Reduced
19
Closed
8
Top Buys
| 1 |
Newmont
NEM
|
$18.6M |
| 2 |
Micron Technology
MU
|
$6.71M |
| 3 |
PayPal
PYPL
|
$5.51M |
| 4 |
Baidu
BIDU
|
$3.68M |
| 5 |
Ginkgo Bioworks
DNA
|
$3.28M |
Top Sells
| 1 |
Alcoa
AA
|
$18.7M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$15.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$14.4M |
| 4 |
Pan American Silver
PAAS
|
$7.25M |
| 5 |
Alibaba
BABA
|
$4.7M |
Sector Composition
| 1 | Healthcare | 30.79% |
| 2 | Materials | 30.33% |
| 3 | Technology | 12.91% |
| 4 | Communication Services | 6.65% |
| 5 | Financials | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $1.85M | 0.3% |
252,712
-114,788
| -31% | -$841K |
|
|
NBIS
27
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| $1.56M | 0.25% |
105,000
| – | – |
|
28
Perrigo
PRGO
$3.27B
| $1.54M | 0.25% |
+60,000
| New | +$1.54M |
|
29
Ciena
CIEN
$13.3B
| $1.45M | 0.23% |
30,000
+12,500
| +71% | +$602K |
|
30
Maravai LifeSciences
MRVI
$350M
| $1.43M | 0.23% |
200,000
+41,849
| +26% | +$300K |
|
|
MREO
31
Mereo BioPharma
MREO
$272M
| $1.25M | 0.2% |
348,128
-56,872
| -14% | -$205K |
|
32
Teladoc Health
TDOC
$1.37B
| $1.22M | 0.19% |
+125,000
| New | +$1.22M |
|
33
Vanda Pharmaceuticals
VNDA
$279M
| $1.09M | 0.17% |
+192,926
| New | +$1.09M |
|
34
Novavax
NVAX
$1.21B
| $1.08M | 0.17% |
85,000
-103,900
| -55% | -$1.32M |
|
35
QuidelOrtho
QDEL
$1.95B
| $1.04M | 0.17% |
+31,253
| New | +$1.04M |
|
36
Forum Energy Technologies
FET
$315M
| $1M | 0.16% |
59,604
| – | – |
|
|
SOL
37
Emeren Group
SOL
$93.4M
| $972K | 0.15% |
647,745
-522,255
| -45% | -$783K |
|
|
MAG
38
MAG Silver
MAG
$2.54B
| $959K | 0.15% |
82,200
| – | – |
|
39
Fate Therapeutics
FATE
$120M
| $941K | 0.15% |
286,900
-29,905
| -9% | -$98.1K |
|
|
PARA
40
DELISTED
Paramount Global Class B
PARA
| $883K | 0.14% |
85,000
-45,000
| -35% | -$468K |
|
41
Xperi
XPER
$278M
| $859K | 0.14% |
+104,660
| New | +$859K |
|
|
NGD
42
New Gold Inc
NGD
$4.67B
| $858K | 0.14% |
440,000
+35,000
| +9% | +$68.3K |
|
|
B
43
Barrick Mining Corporation
B
$45.4B
| $834K | 0.13% |
+50,000
| New | +$834K |
|
44
VEON
VEON
$4.05B
| $670K | 0.11% |
25,830
| – | – |
|
45
Inogen
INGN
$216M
| $610K | 0.1% |
+75,000
| New | +$610K |
|
|
WBA
46
DELISTED
Walgreens Boots Alliance
WBA
| $605K | 0.1% |
50,000
-111,905
| -69% | -$1.35M |
|
47
Galapagos
GLPG
$2.07B
| $520K | 0.08% |
20,999
+4,255
| +25% | +$105K |
|
48
ProQR Therapeutics
PRQR
$237M
| $519K | 0.08% |
312,629
| – | – |
|
49
Roivant Sciences
ROIV
$8.15B
| $423K | 0.07% |
+40,000
| New | +$423K |
|
|
VXRT
50
DELISTED
Vaxart
VXRT
| $402K | 0.06% |
+601,700
| New | +$402K |
|